ACTIVE

CONTIPHARMA

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

-151,8 k €

-33.4% YoY

Gross margin

-95,6 k €

-102.2% YoY

Equity

2,2 M €

-6.5% YoY

Workforce

1,0 ETP

0.0% YoY

What does CONTIPHARMA do?

CONTIPHARMA is a Public limited company incorporated in 1999. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Seraing. It employs on average 1,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0466.820.220

Incorporation

09/09/1999

Legal form

Public limited company

Registered office

Rue de l'Environnement 22
4100 Seraing · WallonieSee on map

Contributed capital

1 907 910,00 €

Latest accounts

31/12/2024

Average workforce

1,0 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores 64200Activities of holding companies 64210Activities of holding companies+2

Joint committees (1)

Signals

Solid equityHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2009		2008		2007
Income statement
Gross margin	-95,6 k €	-102%	-47,3 k €	-21.8%	-38,8 k €	-198%	-13 k €	+14.8%	-15,3 k €	+4.7%	-16,1 k €	-22778%	-70,2 €	-100%	37,6 k €		–		-2,1 k €		–		-1,8 k €	-5.0%	-1,7 k €	-100%	394,9 k €	+11221%	-3,6 k €	-1317%	-250,6 €	+94.1%	-4,3 k €
EBITDA	-174,9 k €	-33.5%	-131 k €	-22.3%	-107,1 k €	-442%	-19,8 k €	-29.1%	-15,3 k €	+4.7%	-16,1 k €	-22778%	-70,2 €	-100%	37,6 k €	-72.9%	138,9 k €	+6839%	-2,1 k €		–		-1,8 k €	-7.9%	-1,7 k €	-100%	394,9 k €	+11221%	-3,6 k €	-1317%	-250,6 €	+94.1%	-4,3 k €
Operating result	-179,6 k €	-33.1%	-134,9 k €	-22.8%	-109,9 k €	-456%	-19,8 k €	-29.1%	-15,3 k €	+4.7%	-16,1 k €	-22778%	-70,2 €	-100%	37,6 k €	-72.9%	138,9 k €	+6839%	-2,1 k €		–		-1,8 k €	-7.9%	-1,7 k €	-100%	394,9 k €	+11221%	-3,6 k €	-1317%	-250,6 €	+94.1%	-4,3 k €
Net result	-151,8 k €	-33.4%	-113,8 k €	+13.1%	-130,9 k €	-314%	-31,6 k €	+48.0%	-60,8 k €	-86.8%	-32,6 k €	-337%	13,7 k €	-34.1%	20,8 k €	-82.7%	120,5 k €	+652%	-21,8 k €	-52.1%	-14,3 k €	+47.1%	-27,1 k €	+22.6%	-35,1 k €	-109%	394,8 k €	+2944%	-13,9 k €	-103%	397 k €	+2453%	-16,9 k €
Balance sheet
Equity	2,2 M €	-6.5%	2,3 M €	-4.7%	2,4 M €	-5.1%	2,6 M €	-1.2%	2,6 M €	-2.3%	2,7 M €	-1.2%	2,7 M €	+0.5%	2,7 M €	+0.8%	2,7 M €	+4.8%	2,5 M €	-0.9%	2,6 M €	-0.6%	2,6 M €	-1.0%	2,6 M €	-1.3%	2,6 M €	+17.2%	2,2 M €	-0.6%	2,3 M €	+2934%	74,5 k €
Total assets	7,2 M €	+29.5%	5,5 M €	+4.4%	5,3 M €	-0.8%	5,4 M €	-0.6%	5,4 M €	+0.2%	5,4 M €	+0.0%	5,4 M €	-0.3%	5,4 M €	-0.0%	5,4 M €	+4.0%	5,2 M €	+0.5%	5,2 M €	+0.8%	5,1 M €	+0.8%	5,1 M €	+93.4%	2,6 M €	+0.4%	2,6 M €	-0.0%	2,6 M €	+515%	426 k €
Cash	611,3 k €	+815%	66,8 k €	+64.0%	40,7 k €	+190%	14 k €	+3443%	396 €	-39.8%	657,9 €	-90.2%	6,7 k €	+991%	616 €	-96.9%	20,1 k €	+7634%	260,3 €		–		7,4 k €	-20.3%	9,3 k €	-16.3%	11,1 k €		–		385,1 €	-23.7%	505 €
Debts	4,6 M €	+63.5%	2,8 M €	+13.6%	2,5 M €	+2.2%	2,4 M €	-0.8%	2,4 M €	+0.2%	2,4 M €	0.0%	2,4 M €	-1.4%	2,5 M €	-0.2%	2,5 M €	+2.1%	2,4 M €	+0.1%	2,4 M €	+0.2%	2,4 M €	0.0%	2,4 M €		–		364,6 k €	+3.7%	351,7 k €	+3.4%	340,3 k €
Other
Workforce	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	+400%	0,2 ETP		–		–		–		–		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 10 ended

Active mandates

Bernard Delhez

Director

Active

Rachel Delhez

Director

Active

Ended mandates

Bernard Delhez

Director · since 25 mai 2021

Ended

Rachel Delhez

Director · since 25 mai 2021

Ended

BEDELCO

Director · 0473.227.762

Represented by Bernard DELHEZ

Ended

BEDELCO

Manager · until 13 juin 2017 · 0473.227.762

Represented by Bernard DELHEZ

Ended

At this address

Other companies at this address

Company	CBE no.
BEDELCO● Active	0473.227.762
Lynx Capital● Active	0830.982.271

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	01/08/2025	27/09/2024	10/07/2023	20/07/2022	25/08/2021	25/09/2020
General meeting	30/07/2025	18/07/2024	27/06/2023	15/06/2022	14/07/2021	05/08/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

17 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	30/07/2025	01/08/2025	French	PDF
Abridged model	31/12/2023	18/07/2024	27/09/2024	French	PDF
Abridged model	31/12/2022	27/06/2023	10/07/2023	French	PDF
Abridged model	31/12/2021	15/06/2022	20/07/2022	French	PDF
Abridged model	31/12/2020	14/07/2021	25/08/2021	French	PDF
Abridged model	31/12/2019	05/08/2020	25/09/2020	French	PDF
Abridged model	31/12/2018	11/06/2019	02/09/2019	French	PDF
Abridged model	31/12/2017	28/06/2018	27/08/2018	French	PDF
Full model	31/12/2016	13/06/2017	26/06/2017	French	PDF
Abridged model	31/12/2015	14/06/2016	17/06/2016	French	PDF
Abridged model	31/12/2014	09/06/2015	28/08/2015	French	PDF
Abridged model	31/12/2013	10/06/2014	11/07/2014	French	PDF
Abridged model	30/11/2012	29/04/2013	03/05/2013	French	PDF
Abridged model	30/11/2011	27/12/2011	27/12/2011	French	PDF
Abridged model	30/11/2009	01/02/2010	02/02/2010	French	PDF
Abridged model	30/11/2008	18/02/2009	26/02/2009	French	PDF
Abridged model	30/11/2007	31/01/2008	29/02/2008	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 10 ended

Active mandates

Bernard Delhez

Director

Active

Rachel Delhez

Director

Active

Ended mandates

Bernard Delhez

Director · since 25 mai 2021

Ended

Rachel Delhez

Director · since 25 mai 2021

Ended

BEDELCO

Director · 0473.227.762

Represented by Bernard DELHEZ

Ended

BEDELCO

Manager · until 13 juin 2017 · 0473.227.762

Represented by Bernard DELHEZ

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates28/06/2021
DENOMINATION - OBJET - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates14/07/2017
DEMISSIONS, NOMINATIONS
PDF
Other07/11/2013
ANNEE COMPTABLE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates11/01/2012
DEMISSIONS, NOMINATIONS
PDF
Capital / shares17/03/2008
OBJET - CAPITAL, ACTIONS
PDF
Registered office03/12/2007
SIEGE SOCIAL
PDF
Capital / shares05/07/2007
ASSEMBLEE GENERALE - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Capital / shares10/01/2007
ASSEMBLEE GENERALE - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024-151,8 k €↓
2023
Annual accounts 2023-113,8 k €↑
2022
Annual accounts 2022-130,9 k €↓
2021
Annual accounts 2021-31,6 k €↑
2020
Annual accounts 2020-60,8 k €↓
2019
Annual accounts 2019-32,6 k €↓
2018
Annual accounts 201813,7 k €↓
2017
Annual accounts 201720,8 k €↓
2016
Annual accounts 2016120,5 k €↑
2015
Annual accounts 2015-21,8 k €↓
2014
Annual accounts 2014-14,3 k €↑
2013
Annual accounts 2013-27,1 k €↑
2012
Annual accounts 2012-35,1 k €↓
2011
Annual accounts 2011394,8 k €↑
2009
Annual accounts 2009-13,9 k €↓
2008
Annual accounts 2008397 k €↑
2007
Annual accounts 2007-16,9 k €
09/09/1999
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

CONTIPHARMA

Overview

What does CONTIPHARMA do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline